Fecal Transplants Boost Brain Health and Revitalize Aging Mice

Fecal microbiome transplantation (FMT) shows promise in enhancing brain adaptability in older adults, similar to that seen in younger individuals. The gut microbiome is linked to mental health and personality traits. A groundbreaking study reveals that older mice receiving FMT from younger counterparts exhibited improved brain plasticity, potentially aiding in the treatment of conditions such as amblyopia, typically treatable only in childhood.

According to Parisa Gazelani, a professor at Oslo Metropolitan University, “This study indicates that microbial communities may regulate critical periods in brain development, shaping when windows of increased plasticity open and close.” This positions the gut microbiome as a key player in neural development, alongside sensory experiences and immune responses.

Neuroplasticity, the brain’s ability to rewire itself, enables effective amblyopia treatment in children by temporarily occluding the stronger eye, forcing the brain to forge new connections with the weaker eye. While plasticity is at its peak during youth, it declines during adolescence as the brain naturally refines unused connections.

Research from the Sant’Anna School of Advanced Studies in Pisa, Italy, led by Paola Tonini, aimed to explore the influence of the gut microbiome on adult brain plasticity. They administered high doses of broad-spectrum antibiotics to 21-day-old mice, inducing significant alterations in their gut microbiota compared to control mice on untreated water. Notably, there was a reduction in bacterial families like Lachnospiraceae, which are involved in producing neuroprotective short-chain fatty acids.

After sealing one eye of each mouse for three days, imaging revealed neuroplasticity responses only in control mice, whose brains demonstrated increased responsiveness to the unsealed eye’s stimulation.

To uncover underlying mechanisms, researchers conducted RNA sequencing, revealing over 1,000 differentially expressed genes linked to myelination and blood-brain barrier permeability in antibiotic-treated mice. “The changes observed were substantial,” stated Tonini.

In a final experiment, fecal microbiota from 30-day-old mice was transplanted into four-month-old adult mice. Only those receiving the younger microbiota exhibited neuroplasticity in response to the eye closure experiment.

If these findings translate to humans, the implications could be profound, as highlighted by Harriet Schellekens from University College Cork, Ireland: “This hints at the microbiome’s potential in enhancing learning, recovery from injuries, and improving resilience against aging and neurological diseases.” However, discerning specific microbial metabolites or strains behind such effects remains a challenge.

Gazelani cautions against premature human extrapolations, noting the complexity of human brains and the significant influence of diet and lifestyle on microbiomes.

Furthermore, the study raises important considerations regarding the long-term implications of childhood antibiotic exposure, particularly in high, prolonged doses. “While antibiotics are crucial for health, these results underscore the need for their judicious use during critical developmental phases,” emphasized Gazelani.